OXGN Financial Facts

Research and development: 2.08M
Net loss: -3.24M
See Full Income Statement

Cash and cash equivalents: 5.17M
Total current liabilities: 1.49M
See Full Balance Sheet

Oxigene, Inc. (OXGN) Earnings

  |   Expand Research on OXGN
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate +6.9% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -1.5% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/9/16 Q116 -$0.13-$0.19 +$0.06N/AN/A N/A Details
8/4/15 Q215 -$0.13-$0.10 -$0.03N/AN/A N/A Details
4/30/15 Q115 -$0.13-$0.13 $0.00N/AN/A N/A Details
3/17/15 Q414 N/A-$0.17 N/A N/AN/A N/A N/A N/A
11/12/14 Q313 -$0.17-$0.23 +$0.06N/AN/A N/A Details
3/18/14 Q412 -$4.67N/A N/A N/AN/A N/A Details
11/8/12 Q312 -$0.13N/A N/A N/AN/A N/A Details
8/8/12 Q212 -$0.14N/A N/A N/AN/A N/A Details